Pathology and Therapeutics of COVID-19: A Review

  • Haleema Anwar CMH Lahore Medical and Dental College,
  • Qudsia U Khan CMH Lahore Medical and Dental College
Keywords: Pandemic, Phylogenetic Analysis, Differential Diagnosis, Incubation Period, Viral Genome


COVID-19 pandemic has taken over the world. Spreading form its epicenter in a seafood market in Wuhan to more than 200 countries, it has caused alarming situations. The viral infection is caused by an RNA virus called SARS-CoV-2. Its genome resembles the SARS-CoV-1 and MERS-CoV genome. COVID-19 cases were first reported in December 2019 in China; it affects the lungs causing mild to severe respiratory disease. No antiviral drug for the infection has been approved yet, but certain drugs are under consideration including Chloroquine, Hydroxychloroquine and Teicoplanin. The review article will first present the structure of the SARS-CoV-2 and compare it to SARS-CoV-1 and MERS-CoV. The article will then highlight its effect on different organs. Finally, it will highlight the therapeutics which are in consideration and which are being used. The article will provide a good insight into the COVID-19 infection.

Author Biographies

Haleema Anwar, CMH Lahore Medical and Dental College,

Medical student

Qudsia U Khan, CMH Lahore Medical and Dental College

Assistant professor, Physiology department


1. Rothan, Hussin & Siddappa, Nagadenahalli. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity. 102433. 10.1016/j.jaut.2020.102433.
2. Huang, Chaolin & Wang, Yeming & Li, Xingwang & Ren, Lili & Zhao, Jianping & Hu, Yi & Zhang, Li & Fan, Guohui & Xu, Jiuyang & Gu, Xiaoying & Cheng, Zhenshun & Yu, Ting & Xia, Jiaan & Wei, Yuan & Wu, Wenjuan & Xie, Xuelei & Yin, Wen & Li, Hui & Liu, Min & Cao, Bin. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 395. 10.1016/S0140-6736(20)30183-5. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Napoli RD: Features, Evaluation and Treatment Coronavirus (COVID-19). StatPearls Publishing, Treasure Island, FL; 2020.
3. Gordon, Calvin & Tchesnokov, Egor & Feng, Joy & Porter, Danielle & Gotte, Matthias. (2020). The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. Journal of Biological Chemistry. jbc.AC120.013056. 10.1074/jbc.AC120.013056.
4. Seah, Ivan & Agrawal, Rupesh. (2020). Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals. Ocular Immunology and Inflammation. 1-5. 10.1080/09273948.2020.1738501.
5. Li, Xiaowei & Manman, Geng & Peng, Yizhao & Meng, Liesu & Lu, Shemin. (2020). Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis. 10.1016/j.jpha.2020.03.001.
6. Cui, Jie & Li, Fang. (2018). Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology. 17. 10.1038/s41579-018-0118-9.
7. Xu, Zhe & Shi, Lei & Wang, Y. & Zhang, Jiyuan & Huang, Lei & Zhang, Chao & Liu, Shuhong & Zhao, Peng & Liu, Hongxia & Zhu, Li & Tai, Yanhong & Bai, Changqing & Gao, Tingting & Song, Jin-Wen & Xia, Peng & Dong, Jinghui & Zhao, Jingmin & Wang, Fu-Sheng. (2020). Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine. 10.1016/S2213-2600(20)30076-X.
8. Zhang, Chao & Shi, Lei & Wang, Fu-Sheng. (2020). Liver injury in COVID-19: management and challenges. The lancet. Gastroenterology & hepatology. 10.1016/S2468-1253(20)30057-1.
9. Mao, Ling & Wang, Mengdie & Chen, Shanghai & He, Quanwei & Chang, Jiang & Hong, Candong & Zhou, Yifan & Wang, David & Li, Yanan & Jin, Huijuan & Hu, Bo. (2020). Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. 10.1101/2020.02.22.20026500.
10. Zheng, Ying-Ying & Ma, Yi-Tong & Zhang, Jin-Ying & Xie, Xiang. (2020). COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 1-2. 10.1038/s41569-020-0360-5.
11. Devaux, Christian & Rolain, Jean-Marc & Colson, Philippe & Raoult, Didier. (2020). New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?. International journal of antimicrobial agents. 105938. 10.1016/j.ijantimicag.2020.105938.
12. Baron, Sophie & Devaux, Christian & Colson, Philippe & Raoult, Didier & Rolain, Jean-Marc. (2020). Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19?. International Journal of Antimicrobial Agents. 105944. 10.1016/j.ijantimicag.2020.105944.
13. Lescure, Francois-Xavier & Bouadma, Lila & Nguyen, Duc & Parisey, Marion & Wicky, Paul-Henri & Behillil, Sylvie & Gaymard, Alexandre & Bouscambert-Duchamp, Maude & Donati, Flora & Le Hingrat, Quentin & Enouf, Vincent & Houhou, Nadhira & Valette, Martine & Mailles, Alexandra & Lucet, Jean-Christophe & Mentre, France & Duval, Xavier & Descamps, Diane & Malvy, Denis & Yazdanpanah, Yazdan. (2020). Clinical and virological data of the first cases of COVID-19 in Europe: a case series. The Lancet Infectious Diseases. 10.1016/S1473-3099(20)30200-0. Ni, Li & Zhou, Ling & Zhou, Min & Zhao, Jianping & Wang, Dao. (2020). Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19 in Wuhan. Frontiers of Medicine. 10.1007/s11684-020-0757-x.
14. Caly, Leon & Druce, Julian & Catton, Mike & Jans, David & Wagstaff, Kylie. (2020). The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research. 104787. 10.1016/j.antiviral.2020.104787.
15. Jiang, Xuan & Rayner, Simon & Luo, Min-Hua. (2020). Does SARS‐CoV‐2 has a longer incubation period than SARS and MERS?. Journal of Medical Virology. 92. 10.1002/jmv.25708.
16. Prompetchara, Eakachai & Ketloy, Chutitorn & Palaga, Tanapat. (2020). Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pacific journal of allergy and immunology. 38. 10.12932/AP-200220-0772.
17. Cortegiani, Andrea & Ingoglia, Giulia & Ippolito, Mariachiara & Giarratano, Antonino named Antonello & Einav, Sharon. (2020). A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. Journal of Critical Care. 10.1016/j.jcrc.2020.03.005.
18. Hassan S, Sheikh F N, Jamal S, et al. (March 21, 2020) Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment. Cureus 12(3): e7355. doi:10.7759/cureus.7355
19. Guo, Yan-Rong & Cao, Qing-Dong & Hong, Zhong-Si & Tan, Yuan-Yang & Chen, Shou-Deng & Jin, Hong-Jun & Tan, Kai-Sen & Wang, De-Yun & Yan, Yan. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research. 7. 10.1186/s40779-020-00240-0.
20. Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee B, Park SJ. Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR. J Korean Med Sci. 2020 Feb;35(6):e79.
21. [Last accessed on 6th April 2020 at 21:00].
How to Cite
Anwar, H., & Khan, Q. U. (2020). Pathology and Therapeutics of COVID-19: A Review. International Journal of Medical Students.